Zurcher Kantonalbank (Zurich Cantonalbank) Syndax Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 12,220 shares of SNDX stock, worth $159,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,220

Previous 12,220 -0.0%

Holding current value

$159,837

Previous $235,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$17.93 - $24.81 $268 - $372	-15 Reduced 0.12%	12,220 $235,000
Q2 2024 Jul 29, 2024	SELL	$18.82 - $23.79 $113,992 - $144,096	-6,057 Reduced 33.11%	12,235 $251,000
Q1 2024 Apr 25, 2024	BUY	$19.71 - $24.57 $82,111 - $102,358	4,166 Added 29.49%	18,292 $435,000
Q4 2023 Jan 30, 2024	BUY	$11.39 - $21.67 $13,235 - $25,180	1,162 Added 8.96%	14,126 $305,000
Q3 2023 Oct 25, 2023	SELL	$14.52 - $21.77 $1,568 - $2,351	-108 Reduced 0.83%	12,964 $188,000
Q2 2023 Aug 07, 2023	BUY	$19.35 - $22.31 $66,544 - $76,724	3,439 Added 35.7%	13,072 $273,000
Q1 2023 May 08, 2023	SELL	$20.66 - $28.98 $2,045 - $2,869	-99 Reduced 1.02%	9,633 $203,000
Q4 2022 Feb 01, 2023	BUY	$20.64 - $26.24 $26,254 - $33,377	1,272 Added 15.04%	9,732 $247,000
Q2 2022 Aug 09, 2022	BUY	$13.64 - $19.48 $43,470 - $62,082	3,187 Added 60.44%	8,460 $163,000
Q1 2022 Apr 21, 2022	SELL	$14.84 - $22.15 $15,329 - $22,880	-1,033 Reduced 16.38%	5,273 $92,000
Q4 2021 Feb 01, 2022	SELL	$15.23 - $22.47 $2,680 - $3,954	-176 Reduced 2.72%	6,306 $138,000
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $124 - $178	9 Added 0.14%	6,482 $124,000
Q2 2021 Jul 30, 2021	BUY	$13.42 - $25.18 $23,203 - $43,536	1,729 Added 36.45%	6,473 $111,000
Q1 2021 May 03, 2021	BUY	$19.28 - $24.59 $91,464 - $116,654	4,744 New	4,744 $106,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Syndax Pharmaceuticals Inc Transaction History